Literature DB >> 31599135

Growth Hormone Deficiency and Excessive Sleepiness: A Case Report and Review of the Literature.

Anisha Gohil1, Erica Eugster2.   

Abstract

The somatotropic axis is intricately involved in normal sleep, as evidenced by the fact that hypothalamic growth hormone-releasing hormone (GHRH) has sleep promoting effects and pituitary growth hormone (GH) release is strongly associated with slow-wave sleep (SWS). Abnormalities in the somatotropic axis, such as GH deficiency of hypothalamic or pituitary origin, result in an alteration of normal sleep patterns which may explain the fatigue reported in these individuals. Sleep disorders such as narcolepsy, in which individuals abnormally enter rapid eye movement (REM) sleep at sleep onset are also associated with an altered GHRH circadian rhythm and abnormal GH secretion. While few studies are available, this review explores what is known about sleep abnormalities in GH deficiency, the effect of treatment on sleep in patients with GH deficiency, and GH secretion in narcolepsy. Emerging evidence suggests a hypothalamic link between narcolepsy and GH secretion. We also describe the unique constellation of isolated idiopathic GH deficiency and severe excessive sleepiness in adopted Nicaraguan siblings, one of which has narcolepsy and the other idiopathic hypersomnia. Copyright© of YS Medical Media ltd.

Entities:  

Keywords:  Growth Hormone Deficiency; Idiopathic Hypersomnia; Narcolepsy; Slow-wave Sleep

Mesh:

Substances:

Year:  2019        PMID: 31599135      PMCID: PMC7262958          DOI: 10.17458/per.vol17.2019.ge.ghdeficiencyandsleepiness

Source DB:  PubMed          Journal:  Pediatr Endocrinol Rev        ISSN: 1565-4753


  42 in total

1.  Sleep apnoea and quality of life in growth hormone (GH)-deficient adults before and after 6 months of GH replacement therapy.

Authors:  Y Peker; J Svensson; J Hedner; L Grote; G Johannsson
Journal:  Clin Endocrinol (Oxf)       Date:  2006-07       Impact factor: 3.478

2.  Slow wave sleep: does it matter?

Authors:  Thomas Roth
Journal:  J Clin Sleep Med       Date:  2009-04-15       Impact factor: 4.062

3.  Central administration of orexin A suppresses basal and domperidone stimulated plasma prolactin.

Authors:  S H Russell; M S Kim; C J Small; C R Abbott; D G Morgan; S Taheri; K G Murphy; J F Todd; M A Ghatei; S R Bloom
Journal:  J Neuroendocrinol       Date:  2000-12       Impact factor: 3.627

4.  The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias.

Authors:  Emmanuel Mignot; Gert Jan Lammers; Beth Ripley; Michele Okun; Sonia Nevsimalova; Sebastiaan Overeem; Jitka Vankova; Jed Black; John Harsh; Claudio Bassetti; Harald Schrader; Seiji Nishino
Journal:  Arch Neurol       Date:  2002-10

5.  Twenty-four-hour secretory patterns of growth hormone, prolactin, and cortisol in narcolepsy.

Authors:  T Higuchi; Y Takahashi; K Takahashi; Y Niimi; A Miyasita
Journal:  J Clin Endocrinol Metab       Date:  1979-08       Impact factor: 5.958

Review 6.  Reciprocal interactions between the GH axis and sleep.

Authors:  Eve Van Cauter; Federica Latta; Arlet Nedeltcheva; Karine Spiegel; Rachel Leproult; Claire Vandenbril; Roy Weiss; Jean Mockel; Jean-Jacques Legros; Georges Copinschi
Journal:  Growth Horm IGF Res       Date:  2004-06       Impact factor: 2.372

7.  Disordered growth hormone and prolactin secretion in primary disorders of sleep.

Authors:  R W Clark; H S Schmidt; W B Malarkey
Journal:  Neurology       Date:  1979-06       Impact factor: 9.910

8.  Effect of growth hormone treatment on sleep EEGs in growth hormone-deficient children.

Authors:  R H Wu; M J Thorpy
Journal:  Sleep       Date:  1988-10       Impact factor: 5.849

9.  The effect of growth hormone administration on human sleep: a dose-response study.

Authors:  W B Mendelson; S Slater; P Gold; J C Gillin
Journal:  Biol Psychiatry       Date:  1980-08       Impact factor: 13.382

10.  Sleep disturbance in children with growth hormone deficiency.

Authors:  M Hayashi; M Shimohira; S Saisho; K Shimozawa; Y Iwakawa
Journal:  Brain Dev       Date:  1992-05       Impact factor: 1.961

View more
  3 in total

Review 1.  Narcolepsy Presentation in Diverse Populations: an Update.

Authors:  Karen Spruyt
Journal:  Curr Sleep Med Rep       Date:  2020-11-25

2.  Significance of recombinant human growth hormone therapy in promoting growth and development of children with idiopathic short stature.

Authors:  Wenbiao Han; Jing Zhang; Tao Song; Yanni Han
Journal:  Pak J Med Sci       Date:  2022 Sep-Oct       Impact factor: 2.340

Review 3.  Growth Hormone and the Human Hair Follicle.

Authors:  Elijah J Horesh; Jérémy Chéret; Ralf Paus
Journal:  Int J Mol Sci       Date:  2021-12-08       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.